functional dyspepsia, FD
Conditions
Interventions
PWC-treated group:Pingwei capsules-treated
mosapride-treated group:mosapride-treated
Sponsors
Affiliated Hospital of Gansu University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) according to Rome III diagnostic criteria of functional dyspepsia and FD diagnostic criteria of self-made liver stagnation and spleen deficiency type; (2) Aged 18 to 70 years old male and female; (3) the subjects volunteered to take part in the clinical and experimental studies and signed an informed consent letter; (4) the subjects were not treated with the relevant drugs within one month and could cooperate with the treatment for a course of treatment.
Exclusion criteria
Exclusion criteria: (1) Patients who had a peptic ulcer, gastric mucosa with severe atypical hyperplasia, or canceration in pathological diagnosis were excluded; (2) Patients with liver, gallbladder, pancreas, spleen, kidney, connective, neuromuscular or other systemic diseases; (3) Patients with severe heart, brain, vessels, liver, kidney, hematopoietic system, endocrine system or other primary diseases; (4) Women during pregnancy or lactation; (5) Patients with a mental or legal disability; (6) Patients taking part in or just ending other clinical trials; (7) Patients who had an allergic constitution or may be allergic to the test drug; (8) Patients with a history of alcohol and drug abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| electrogastrogram parameter.;Cholecystokinin;Growth Hormonehrelin;the Score of TCM symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastroscope;pathological; | — |
Countries
China
Contacts
Public ContactLongde Wang
Affiliated Hospital of Gansu University of Chinese Medicine
Outcome results
None listed